Transdermal Versus Intralesional Betamethasone for Keloids
Transdermal Versus Intralesional Betamethasone for Keloids
Active, not recruiting · NCT07835438 · Registry updated 2026-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Transdermal Versus Intralesional Betamethasone for Keloids | Collagen Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, keloid, severe cutaneous adverse reaction | Active, not recruiting | Not applicable | 2026-09-23 | NCT07835438 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| First Hospital of China Medical University | 92 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| First Hospital of China Medical University | Shenyang | China | 3 |